Trial Profile
Safety and Efficacy Study in Non-Responder Hepatitis C Genotype 1 Patients With PHN121.
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs PHN 121 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Acronyms ENCHAMP
- 25 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 24 Jan 2010 New trial record